7th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders is organized by Icahn School of Medicine at Mount Sinai (ISMMS) and will be held on Nov 21, 2020. Accreditation: The Icahn School of Medicine at Mount Sinai designates thislive activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity / AMA PRA Category 1 Credits™ (6.75 hours), Non-Physician Attendance (6.75 hours) Course Overview: The 7th Annual Advances in Neurology is a full-day virtual CME event that will provide clinicians with an update on diagnostic processes, cutting-edge technologies, and innovative management strategies in these 8 areas of neurology: headache, movement disorders and deep brain stimulation, epilepsy, neurological manifestations of COVID-19, stroke, multiple sclerosis, neuromuscular disease, physician-patient communication. Through didactic lecture, case presentations, and interactive discussions with expert clinicians, attendees will be better enabled to diagnose and manage patients living with neurologic disorders in 2020 and beyond. Patient simulators will interact with faculty to provide an enhanced learning experience for participants. Objectives: • Discuss existing, new, and potential options for migraine treatment and prevention including oral medications, devices, injectables, and interventional therapies. • Explain the updated guidelines and criteria for diagnosing and categorizing multiple sclerosis and describe a comprehensive management plan. • Identify appropriate treatment approaches for acute ischemic stroke and recognize cases that are appropriate for referral to comprehensive stroke centers offering acute endovascular interventions. • Discuss the neurological manifestations of COVID-19. • Explain the value of electrodiagnostic testing (nerve conduction studies, electromyography, and neuromuscular ultrasound) in securing a neuromuscular disease diagnosis. • Describe surgical options for the treatment of epilepsy and distinguish an ideal candidate. • Identify a movement disorder patient who is a candidate for deep brain stimulation (DBS) surgery. • Explain how autonomic function testing improves recognition and diagnosis of chronic pain syndromes, and more broadly, neurological illnesses. • Outline the elements of a communication plan for delivering bad news to a patient with neurological disease.

Tuberculosis Course for Physicians is organized by ContinuingEducation.com - OnCourse Learning Corporation. Release Date: Oct 11, 2012 Expiration Date: Nov 01, 2020 The target audience for this medical event is physicians. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credit. This course will serve as a review and update on late 1970s and early 1980s, healthcare professionals often boasted that tuberculosis had been eradicated, and consequently, because of declining cases and the public health system’s ability to treat patients without a prolonged period of confinement, most TB programs and sanitariums were closed. With the rapid growth of a new disease, AIDS, and worsening socioeconomic conditions in the mid-1980s, health officials warned that this “white plague” had returned to pose a serious threat to the public’s health. Worldwide deaths from TB totaled 1.8 million in 2015. Conference Objectives are : The goal of this tuberculosis continuing education program is to update nurses’ and physicians’ knowledge about the prevention, assessment, diagnosis, treatment, and follow-up measures for tuberculosis and multidrug-resistant tuberculosis. After studying the information presented here, you will be able to: • Identify risk factors for tuberculosis and multidrug-resistant tuberculosis • Identify methods to prevent, assess, and diagnose tuberculosis and multidrug-resistant tuberculosis • Identify appropriate treatment and follow-up measures for tuberculosis and multidrug-resistant tuberculosis Additional details will be posted as soon as they are available.

Hepatitis C: A Complete Guide for Patients and Families is organized by Anderson Continuing Education. Conference Description: Hepatitis C affects between three and four million people in the United States. Many people with hepatitis C infection have not been diagnosed and remain unaware that they have the disease. Despite the progress made in the diagnosis and treatment of hepatitis C over the last 25 years, successful treatment of the disease remains a major challenge. Most people with the disease have not been diagnosed, and many medical professionals and the public are often only partially educated about the disease. Although the internet can provide valuable information to individuals about hepatitis C quickly and inexpensively, some of this information may be unreliable and purely anecdotal. When a hepatitis C infection goes undiagnosed, it progresses to cirrhosis in approximately one-third of infected individuals, and liver transplantation may become the only option to cure the disease. Yet because of organ shortages, timely liver transplantation may become difficult to impossible for most people. Hepatitis C is believed to be one of the leading causes of liver cancer, and an increasing number of people with HIV infections are also infected with hepatitis C. It has been suggested that in HIV-positive populations, hepatitis C may emerge as a major killer, negating some of the advances achieved in the treatments of HIV. Additional details will be posted as soon as they are available.

Zika: The Pandemic Threat Course for Dietitians is organized by ContinuingEducation.com - OnCourse Learning Corporation. Course Originally Released on: 2/17/2016 Date of Most Recent Review: 6/4/2019 Course Termination/Update Date: 6/30/2022 The target audience for this medical event is interprofessional audience, including nurses, dietitians, EMTs and paramedics, health educators, lab professionals, pharmacists, physicians, respiratory therapists, and social workers. This Conference has been approved for a maximum of 1.00 CPEU. Conference Description : Zika, a mosquitoborne viral infection, is the most recent of four arboviruses (arthropodborne viral diseases) that have spread to the Western Hemisphere in the last 20 years. Zika virus has been identified as a cause of congenital microcephaly, a potentially devastating birth defect in which babies are born with small heads and underdeveloped brains. The virus has also been linked to an increase in Guillain-Barrré syndrome, myelitis, and meningoencephalitis. This CE program will inform and heighten awareness of nurses, advanced practice nurses, physicians, lab professionals, pharmacists, and other healthcare providers about the emergence of Zika virus both in the U.S. and internationally. Conference Objectives are : • Identify the signs and symptoms of Zika virus infection. • Discuss the Centers for Disease Control and Prevention recommendations for pregnant women and testing of infants with possible congenital infection with Zika virus. • List the prevention measures for mosquitoborne illness. • Describe how the interprofessional team can collaborate to promote improved outcomes and prevent Zika virus infection. Additional details will be posted as soon as they are available.

Zika: The Pandemic Threat Course for Physician is organized by ContinuingEducation.com - OnCourse Learning Corporation and will be held from Feb 17, 2016 - Jun 04, 2022. The target audience for this medical event is an interprofessional audience, including nurses, dietitians, EMTs and paramedics, health educators, lab professionals, pharmacists, physicians, respiratory therapists, and social workers. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credit. Course Description : Zika, a mosquito-borne viral infection, is the most recent of four arboviruses (arthropod-borne viral diseases) that have spread to the Western Hemisphere in the last 20 years. It follows the dengue virus, which became re-established in the 1990s after the failure of mosquito eradication programs; the West Nile virus that emerged in 1999; and chikungunya in 2013. Zika virus has been identified as a cause of congenital microcephaly, a potentially devastating birth defect in which babies are born with small heads and underdeveloped brains. The virus has also been linked to an increase in Guillain-Barrré syndrome, myelitis, and meningoencephalitis. This CE program will inform and heighten awareness of nurses, advanced practice nurses, physicians, lab professionals, pharmacists, and other healthcare providers about the emergence of Zika virus both in the U.S. and internationally. Objectives: The goal of this Zika virus continuing education program is to inform nurses, advanced practice nurses, physicians, lab professionals, pharmacists, and other healthcare providers about the emergence of Zika virus both in the U.S. and internationally. After studying the information presented here, you will be able to: • Identify the signs and symptoms of Zika virus infection • Discuss the Centers for Disease Control and Prevention recommendations for pregnant women and testing of infants with possible congenital infection with Zika virus • List the prevention measures for mosquito-borne illness • Describe how the interprofessional team can collaborate to promote improved outcomes and prevent Zika virus infection

Management of Nosocomial Pneumonia is organized by the American Association of Critical-Care Nurses (AACN). This online Cm conference is held from Mar 01, 2018 - Mar 01, 2021. Accreditation : The American Association of Critical-Care Nurses (AACN) is an authorized provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been recognized as an accreditated provider of continuing education in nursing by the California State Board of Nursing, California Provider Number CEP01036 for 1 contact hours. Activity Summary : This article reviews modern recommendations for the management of nosocomial pneumonia, based on the 2016 clinical practice guidelines produced by the Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS). Definitions and relevant therapy are presented, as there is major differential treatment from the original 2005 guidelines. These changes involve the replacement of the term healthcare-associated pneumonia (HCAP), the use of antibiograms, the retreat of aminoglycoside mono-therapy and the use of adjunctive gasped antibiotic therapy and a recommended treatment duration of 7 days for most patients. Objectives : • Review major changes in the 2016 ATS/IDSA nosocomial pneumonia guidelines. • Enter major risk factors & microbiological causes of pneumonia. • Consult proper antibiotic therapy & monitoring parameters for the management of nosocomial pneumonia. Additional details will be posted as soon as they are available.

Community-Acquired Pneumonia (CAP) is organized by American Nurses Association (ANA) and will be held during Apr 06, 2018 - Dec 01, 2020. This CME Conference has been approved for a maximum of 1.08 Contact Hours. Overview Community-acquired Pneumonia (CAP) is exactly what it sounds like - a lung infection acquired while out and about in the world. The cause may be a virus, bacteria, or fungus. The estimated cost of treating CAP in the United States is about $12.2 billion a year. Inpatient treatment ranges from $7,500 to $10,227 per admission, whereas outpatient treatment ranges from $150 to $350 per patient. This difference demonstrates the need for accurate diagnosis and appropriate treatment. With accurate diagnosis, patients can be appropriately treated in and out of the hospital. The goal of this article is to provide nurses with information on how to better care for patients with CAP. Key Learning Outcomes • Identify the causes of and risk factors for community-acquired pneumonia (CAP). • Describe the assessment of the patient with CAP. • Discuss the management of the patient with CAP. Additional details will be posted as soon as they are available.

Cellulitis and Soft Tissue Infections is organized by American College of Physicians (ACP) and will be held during Apr 23, 2018 - Feb 06, 2021. This CME Conference has been approved for a maximum of 2.0 AMA PRA Category 1 Credits and MOC Points. Course Description: Cellulitis and soft tissue infections are a diverse group of diseases that range from uncomplicated cellulitis to necrotizing fasciitis. Management of predisposing conditions is the primary means of prevention. Cellulitis is a clinical diagnosis and thus is made on the basis of history and physical examination. Imaging may be helpful for characterizing purulent soft tissue infections and associated osteomyelitis. Treatment varies according to the type of infection. The foundations of treatment are drainage of purulence and antibiotics, the latter targeted at the infection's most likely cause. Additional details will be posted as soon as they are available.

Advances on the AIDS Horizon 2017 is organized by Anderson Continuing Education and will be held from May 25, 2018 - Dec 31, 2020. This CME Conference has been approved for a maximum of 1 Contact Hour. Conference Description: • The history of HIV • HIV life cycle • Stages of HIV • Transmission • HIV and AIDS in the United States • Laboratory tests for HIV • Other testing matters: Confidential, anonymous, mandated tests, and counseling • Treatment • Occupational HIV transmission and prevention among health care personnel • Antiretroviral prophylaxis follwing exposure to HIV from sexual activity, intravenous drug use or other non-occupational exposure Additional details will be posted as soon as they are available.

Bailey & Scott's Diagnostic Microbiology, 14th Edition is organized by Anderson Continuing Education and will be held from May 25, 2018 - Dec 31, 2020. This CME Conference has been approved for a maximum of 48 Contact Hours. Conference Description: Serving as the #1 bench reference for practising microbiologists, Bailey & Scott's Diagnostic Microbiology, 14th Edition features hundreds of step-by-step procedures, updated visuals, new case studies, and new material on the latest trends and equipment in clinical microbiology - including automation, automated streaking, MALDI-TOF, and incubator microscopes. • NEW! Coverage of automation, automated streaking, MALDI-TOF, and incubator microscopes keeps you in the know on these progressing topics. • NEW! Updated images provide a more vivid look at book content and reflect the latest procedures. • NEW! Thoroughly reviewed and updated chapters equip you with the most current information. • NEW! Significant lab manual improvements provide an excellent learning resource at no extra cost. Features: • More than 800 detailed, full-colour illustrations aid comprehension and help in visualizing concepts. • Expanded sections on parasitology, mycology, and virology eliminate the need to purchase separate books on this material. • General and Species boxes in the organism chapters highlight the important topics that will be discussed in the chapter. • Case studies provide the opportunity to apply information to a variety of diagnostic scenarios and help improve decision-making and critical thinking skills. • Hands-on procedures include step-by-step instructions, full-colour photos, and expected results. • A glossary of terms is found at the back of the book for quick reference. • Learning resources on the Evolve companion website enhance learning with review questions and procedures. Additional details will be posted as soon as they are available.